Mylan Inc 

MYL:NASDAQ

LastChange / % ChangeDividend YieldVolume
22.80 0.0700   0.31%0.00%2,259,236

Market data is delayed by at least 20 minutes.

Exclusive Features

When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes.

For full analysis details, Log In with Scottrade or you can:
  •  
    Advanced Charts

  •  
    Embed Chart

    Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

  • 1 Day
  • 5 Day
  • 6 Mo
  • 1 Yr
  • 5 Yr
 
 
 

Latest News Headlines for Mylan Inc

Mylan Laboratories (MYL) Showing Bullish Technicals With Support At $22.25
5 days 11 hours 53 minutes ago - FreshBrewedMedia
Mylan Inc (NASDAQ: MYL) closed Tuesday's trading session at $22.58. In the past year, the stock has hit a 52-week low of $16.55 and 52-week high of $23.63. Mylan Laboratories stock has been showing support around $22.25 and resistance in the $22.89 range. Technical indicators for the stock are Bullish and S&P; gives MYL a very positive 5 STARS (out of 5) strong buy rating. For a hedged play on this stock, look at the Jul '11 $23.00 covered call for a net debit in the $20.99 area. That is also the break-even stock price for this trade. This covered call has a duration of 185 days, provides 7.04% downside protection and an assigned return rate of 9.58% for an annualized return rate of 18.89% (for comparison purposes only). A lower-cost hedged play for this stock would use a longer term call option in place of the covered call stock purchase. To use this strategy look at going long the MYL Jan '12 $17.50 call and selling the Jul '11 $23.00 call for a total debit of $4.51. The trade has a lifespan of 185 days and would provide 2.52% downside protection and an assigned return rate of 21.95% for an annualized return rate of 43% (for comparison purposes only). Mylan Laboratories does not pay dividends at this time.
Watch for Mylan to Potentially Pullback after Gaining 0.45% Yesterday (MYL)
6 days 18 hours 49 minutes ago - Comtex SmarTrend(R)
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $22.08 to a high of $22.55. Yesterday, the shares gained 0.45%, which took the trading range above the 3-day high of $22.54 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend's Option Scanner Detects Unusual Activity in Mylan (MYL)
7 days 6 hours 18 minutes ago - Comtex SmarTrend(R)
Shares of Mylan (NASDAQ:MYL) are trading 0.7% higher today, recently trading at $22.47. The stock has been drifting higher over the past ten trading days and is currently trading in a technical uptrend.
View more recent headlines
 
 
 
 
 
 
More Filings

Latest Annual and Quarterly SEC Filings

10-K
February 26, 2010
This report contains detailed information about the company's business finances and management.
10-Q
October 28, 2010
Quarterly reports contain financial statement, a discussion from management and a list of company events (stock splits, acquisitions, etc.)
 
 
 
Company Background
Mylan Inc. (Mylan) is a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic and branded generic pharmaceuticals, specialty pharmaceuticals and active pharmaceutical ingredients (APIs). It operates through two business segments: Generics and Specialty. The Generics Segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule or transdermal patch form, as well as API. The Specialty Segment engages mainly in the manufacture and sale of branded specialty nebulized and injectable products. As of December 31, 2009, Mylan marketed more than 900 different products covering an array of therapeutic categories to consumers in more than 140 countries and territories across the globe. During the year ended December 31, 2009, the Company acquired approximately 25% of the remaining interest in Matrix Laboratories Limited, bringing both its total ownership and control to over 96%.
Bid/Size
-- / --
Ask/Size
-- / --
Price Open
22.63
Previous Close
22.73
Day High
22.80
Day Low
22.60
52wk High/Date
23.63 / 4/5/2010
52wk Low/Date
16.55 / 7/1/2010
Beta
0.72
Market Capitalization
9.92B
Shares Outstanding
435.22M
Volatility Avg
24.47
Avg Vol(10 day)
5.56M
P/E Ratio
32.6x
EPS (TTM)
0.70
Annualized Rate
-- / --
Yield
0.00%
Dividend Announcement
--
Ex-Date
--
Date of Record
--
Payable
0.00 - --
Payable Date
--
Last Trade as of 1/14/2011 4:00 PM ET

Exclusive Content

When you open an account with Scottrade, you will get premium content on the News & Content page, including:

  • Standard & Poor's News and Commentary
  • Dow Jones News
  • Briefing News and Commentary
  • Market Edge On the Edge Commentary
For full analysis details, Log In with Scottrade or you can:
 
 
 

MYL Mylan Inc vs. Peers

Peers 
MYL
Mylan Inc
7.90%
JNJ
Johnson & Johnson
1.13%
MRK
Merck & Co., Inc.
-5.02%
ABT
Abbott Laboratories
-2.13%
PFE
Pfizer Inc.
4.74%
MYL
Mylan Inc
0.00%
JNJ
Johnson & Johnson
3.45%
MRK
Merck & Co., Inc.
4.44%
ABT
Abbott Laboratories
3.75%
PFE
Pfizer Inc.
4.36%
MYL
Mylan Inc
0.31%
JNJ
Johnson & Johnson
-0.57%
MRK
Merck & Co., Inc.
-1.33%
ABT
Abbott Laboratories
-1.01%
PFE
Pfizer Inc.
0.66%
Compare these stocks
 
 
 
© 2011 Scottrade

Brokerage Products and Services offered by Scottrade, Inc. - Member FINRA and SIPC

Online market and limit stock trades are just $7 for stocks priced $1 and above.

Any specific securities, or types of securities, used as examples are for demonstration purposes only. No information on this Web site should be considered a recommendation or None of the information provided should be considered a recommendation or solicitation to invest in, or liquidate, a particular security or type of security.

Investors should consider the investment objectives, risks, and charges and expenses of a mutual fund carefully before investing. A mutual fund's prospectus contains this and other information about the mutual fund. Prospectuses are available through our trading site or through a Scottrade Branch Office. The prospectus should be read carefully before investing. No transaction fee (NTF) funds are subject to the terms and conditions of the NTF funds program. Scottrade is compensated by the funds participating in the NTF program through recordkeeping, shareholder, or SEC 12b-1 fees.

Investors should consider the investment objectives, charges, expense, and unique risk profile of an Exchange Traded Fund (ETF) carefully before investing. Leveraged and Inverse ETFs may not be suitable for long-term investors and may increase exposure to volatility through the use of leverage, short sales of securities, derivatives and other complex investment strategies. A prospectus contains this and other information about the ETF and should be obtained from the issuer. The prospectus should be read carefully before investing.

Margin trading involves interest charges and risks, including the potential to lose more than deposited, or the need to deposit additional collateral in a falling market. Margin Disclosure Statement (PDF) is available for download, or it is available at one of our branch offices. It contains information on our lending policies, interest charges, and the risks associated with margin accounts.

Options involve risk and are not suitable for all investors. Detailed information on our policies and the risks associated with options can be found in the Scottrade Options Application and Agreement, Brokerage Account Agreement, and by downloading the Characteristics and Risks of Standardized Options and Supplements (PDF) from The Options Clearing Corporation, or by requesting a copy from your local branch office. Supporting documentation for any claims will be supplied upon request.

Market volatility, volume, and system availability may impact account access and trade execution.

Testimonials may not be representative of the experience of other clients and are no guarantee of future performance or success.